BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 28, 2011
View Archived Issues
Novel oncolytic agent RX-5902 presented
Read More
MCT 4 expression is a marker of radiotherapy outcome in oropharyngeal squamous cell carcinoma
Read More
LB-100 enhances antitumor activity of combined veliparib/temozolomide treatment in vivo
Read More
Upsher-Smith Laboratories details development of extended-release topiramate formulation
Read More
Astellas Pharma claims new lysophospholipid LPA1 receptor antagonists
Read More
Aflibercept improves overall survival in phase III trial in metastatic colorectal cancer
Read More
TRAIL receptor agonist APG-350 potently induces apoptosis in cancer cells
Read More
Adeona Pharma completes trial of reaZin in patients with cognitive impairment
Read More
Centocor and Medivir patent new series of HCV NS5B inhibitors
Read More
Merck & Co. claims new mitogen-activated protein kinase inhibitors for cancer
Read More
Merck & Co. patents new positive allosteric modulators of muscarinic acetylcholine M1 receptor
Read More
A.P. Pharma meets with FDA to discuss NDA resubmission for APF-530
Read More
Rivastach patch is approved in Japan for Alzheimer's-type dementia
Read More
XenoPort and FDA agree on SPA for arbaclofen placarbil phase III trial
Read More
New ionotropic glutamate receptor agonists presented
Read More
FDA grants orphan drug status to active ingredient of Provectus Pharma's PV-10 in HCC
Read More
Genta begins tesetaxel trial in Japan in advanced cancer
Read More
Glubes approved in Japan to improve postprandial plasma glucose in patients with type 2 diabetes
Read More
IQ Therapeutics completes dosing in phase I IQNLF trial
Read More
European Commission approves Novartis' Rasilamlo for high blood pressure
Read More
Lipacreon approved in Japan as a pancreatic digestive enzyme replacement
Read More
FDA committee recommends approval of Victrelis for chronic HCV genotype 1 infection
Read More
FDA issues complete response letter regarding NDA for Aricept patch
Read More
Tarix Pharma enrolls first patient in phase I TXA-127 trial
Read More
Boehringer Ingelheim enrolls first patient in phase III BI-2013 trial in chronic hepatitis C
Read More
Baxter receives approval in Japan for inhaled anesthetic Suprane
Read More
